{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:59:07Z","timestamp":1792205947989,"version":"4.4.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ftd.0b013e318260f7b3","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T10:06:40Z","timestamp":1346148400000},"page":"599-603","source":"Crossref","is-referenced-by-count":49,"title":["Reduced Valproic Acid Serum Concentrations Due to Drug Interactions With Carbapenem Antibiotics"],"prefix":"10.1097","volume":"34","author":[{"given":"Min Kyu","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Kyung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Jeong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Goo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":". Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"R2-18-20210129","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":". Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"R3-18-20210129","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/jac\/dkg404","article-title":"Ertapenem, the first of a new group of carbapenems.","volume":"52","author":"Shah","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"R4-18-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14787210.3.1.23","article-title":". Ertapenem: review of a new carbapenem.","volume":"3","author":"Zhanel","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R5-18-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","article-title":". Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenembetamipron.","volume":"39","author":"Nagai","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"R6-18-20210129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","article-title":". Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin.","volume":"42","author":"De Turck","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"R7-18-20210129","first-page":"258","article-title":". Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics: a discussion of three cases in Spanish.","volume":"27","author":"Llinares Tello","year":"2003","journal-title":"Farm Hosp"},{"key":"R8-18-20210129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","article-title":". Acute seizures due to a probable interaction between valproic acid and meropenem.","volume":"39","author":"Coves-Orts","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R9-18-20210129","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/08830738050200051401","article-title":"Seizure worsening caused by decreased serum valproate during meropenem therapy.","volume":"20","author":"Santucci","year":"2005","journal-title":"J Child Neurol"},{"key":"R10-18-20210129","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","article-title":"The effect of carbapenem antibiotics on plasma concentrations of valproic acid.","volume":"43","author":"Mancl","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R11-18-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics.","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab Rev"},{"key":"R12-18-20210129","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1211\/0022357011776171","article-title":". Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats.","volume":"53","author":"Torii","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"R13-18-20210129","first-page":"80","article-title":"A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.","volume":"18","author":"Semmes","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"R14-18-20210129","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1023\/A:1013046229699","article-title":". Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.","volume":"18","author":"Yokogawa","year":"2001","journal-title":"Pharm Res"},{"key":"R15-18-20210129","first-page":"1484","article-title":"Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats.","volume":"28","author":"Yamamura","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R16-18-20210129","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.20338","article-title":". Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.","volume":"94","author":"Omoda","year":"2005","journal-title":"J Pharm Sci"},{"key":"R17-18-20210129","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/AAC.31.11.1718","article-title":"Biliary excretion of imipenem-cilastatin in hospitalized patients.","volume":"31","author":"Graziani","year":"1987","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e318260f7b3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:39:52Z","timestamp":1620952792000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201210000-00018"}},"subtitle":["Overview of 6 Cases"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318260f7b3","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}